← Back to Search
Succinate Dehydrogenase Inhibition Leads To Epithelial-mesenchymal Transition And Reprogrammed Carbon Metabolism
P. Aspuria, S. Lunt, Leif Väremo, L. Vergnes, M. Gozo, J. Beach, B. Salumbides, K. Reue, W. Wiedemeyer, J. Nielsen, B. Karlan, S. Orsulic
Published 2014 · Medicine, Chemistry, Biology
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
BackgroundSuccinate dehydrogenase (SDH) is a mitochondrial metabolic enzyme complex involved in both the electron transport chain and the citric acid cycle. SDH mutations resulting in enzymatic dysfunction have been found to be a predisposing factor in various hereditary cancers. Therefore, SDH has been implicated as a tumor suppressor.ResultsWe identified that dysregulation of SDH components also occurs in serous ovarian cancer, particularly the SDH subunit SDHB. Targeted knockdown of Sdhb in mouse ovarian cancer cells resulted in enhanced proliferation and an epithelial-to-mesenchymal transition (EMT). Bioinformatics analysis revealed that decreased SDHB expression leads to a transcriptional upregulation of genes involved in metabolic networks affecting histone methylation. We confirmed that Sdhb knockdown leads to a hypermethylated epigenome that is sufficient to promote EMT. Metabolically, the loss of Sdhb resulted in reprogrammed carbon source utilization and mitochondrial dysfunction. This altered metabolic state of Sdhb knockdown cells rendered them hypersensitive to energy stress.ConclusionsThese data illustrate how SDH dysfunction alters the epigenetic and metabolic landscape in ovarian cancer. By analyzing the involvement of this enzyme in transcriptional and metabolic networks, we find a metabolic Achilles’ heel that can be exploited therapeutically. Analyses of this type provide an understanding how specific perturbations in cancer metabolism may lead to novel anticancer strategies.
This paper references
Über die Entstehung der Krebszellen
O. Warburg (1956)
[Origin of cancer cells].
O. Warburg (1956)
2. SEER Cancer Statistics Review
Uncouplers of oxidative phosphorylation.
P. G. Heytler (1979)
 Uncouplers of oxidative phosphorylation
P. G. Heytler (1979)
Uncouplers of oxidative phosphorylation.
H. Terada (1990)
Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I*
M. Y. El-Mir (2000)
An RCAS-TVA-based approach to designer mouse models
S. Orsulic (2002)
The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial Origin
J. Seidman (2004)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.
M. Selak (2005)
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
P. Pollard (2005)
A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance.
D. Xing (2005)
Uncovering transcriptional regulation of metabolism by using metabolic network topology.
K. Patil (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
M. Selak (2005)
BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis
Steffen Durinck (2005)
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
A. King (2006)
HOXB13 promotes ovarian cancer progression
J. Miao (2007)
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence.
S. Ansieau (2008)
Twist promotes tumor cell growth through YB-1 expression.
M. Shiota (2008)
Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy
Joshua Munger (2008)
Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells
A. Cervera (2009)
SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling.
W. Kaelin (2009)
Metabolomic analysis and visualization engine for LC-MS data.
E. Melamud (2010)
The landscape of somatic copy-number alteration across human cancers
R. Beroukhim (2010)
An energetic tale of AMPK-independent effects of metformin.
Russell A. Miller (2010)
Deregulation of H3K27 methylation in cancer
E. Martínez-García (2010)
Succinate Dehydrogenase Is a Direct Target of Sirtuin 3 Deacetylase Activity
Lydia W. S. Finley (2011)
The ins and outs of the epithelial to mesenchymal transition in health and disease.
M. Nieto (2011)
Integrated Genomic Analyses of Ovarian Carcinoma
D. Bell (2011)
SDH mutations in cancer.
Chiara Bardella (2011)
Aerobic glycolysis: meeting the metabolic requirements of cell proliferation.
S. Lunt (2011)
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase
C. Frezza (2011)
Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models
J. Cheong (2011)
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.
Mengtao Xiao (2012)
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response
L. Kruidenier (2012)
Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC
W. Liu (2012)
Is There a Link between Mitochondrial Reserve Respiratory Capacity and Aging?
C. Desler (2012)
LC-MS data processing with MAVEN: a metabolomic analysis and visualization engine.
Michelle F. Clasquin (2012)
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
Recurrent Hemizygous Deletions in Cancers May Optimize Proliferative Potential
N. Solimini (2012)
Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations.
Céline Loriot (2012)
Zbtb16 has a role in brown adipocyte bioenergetics
C. Plaisier (2012)
IsoCor: correcting MS data in isotope labeling experiments
P. Millard (2012)
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
E. Cerami (2012)
Cumulative Haploinsufficiency and Triplosensitivity Drive Aneuploidy Patterns and Shape the Cancer Genome
T. Davoli (2013)
Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods
Leif Väremo (2013)
Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling.
Tao Zhang (2013)
Integrating genomic, epigenomic, and transcriptomic features reveals modular signatures underlying poor prognosis in ovarian cancer.
W. Zhang (2013)
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor.
J. Killian (2013)
Succinate Dehydrogenase 5 (SDH5) Regulates Glycogen Synthase Kinase 3β-β-Catenin-mediated Lung Cancer Metastasis*
J. Liu (2013)
SDH mutations establish a hypermethylator phenotype in paraganglioma.
E. Letouzé (2013)
MYC, metabolism, cell growth, and tumorigenesis.
C. Dang (2013)
Cancer statistics, 2013
R. Siegel (2013)
The epigenetics of epithelial-mesenchymal plasticity in cancer
W. Tam (2013)
Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.
Chenfang Dong (2013)
Twist1 Promotes Gastric Cancer Cell Proliferation through Up-Regulation of FoxM1
Jianxin Qian (2013)
Regulatory networks defining EMT during cancer initiation and progression
B. D. Craene (2013)
A New Specific Succinate-Glutamate Metabolomic Hallmark in Sdhx-Related Paragangliomas
A. Imperiale (2013)
The role of complex II in disease.
A. Hoekstra (2013)
BP: Loss of FBP1 by snail-mediated repression provides metabolic advantages in basal-like breast cancer
C Dong (2013)
Cancer statistics CA Cancer J Clin
R Siegel (2013)
Genomescale metabolic modeling of hepatocytes leads to identification of serine deficiency in non-alcoholic fatty liver disease
A Mardinoglu (2013)
Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease.
A. Mardinoglu (2014)
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
L. Yang (2014)
Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma
F. Gatto (2014)
Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Cancer statistics , 2013 SEER Cancer Statistics Review , 1975 – 2010
This paper is referenced by
Ad-apoptin inhibits glycolysis, migration and invasion in lung cancer cells targeting AMPK/mTOR signaling pathway.
Interplay between Metabolism Reprogramming and Epithelial-to-Mesenchymal Transition in Cancer Stem Cells
Yoann Daniel (2021)
Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers
O. Zidi (2021)
Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses
Inseo Choi (2021)
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
Sayani Patra (2021)
Evaluation of disease staging and chemotherapeutic response in non-small cell lung cancer from patient tumor-derived metabolomic data.
Hunter A. Miller (2021)
Metabolic landscapes in sarcomas
Richard Miallot (2021)
High Throughput Analysis Reveals Changes in Gut Microbiota and Specific Fecal Metabolomic Signature in Hematopoietic Stem Cell Transplant Patients
Soumaya Kouidhi (2021)
Mitochondrial Tumor Suppressors—The Energetic Enemies of Tumor Progression
Pavel Jakoube (2021)
Mitochondria: The metabolic switch of cellular oncogenic transformation.
Y. Tan (2021)
МИТОХОНДРИИ ТРАНСФОРМИРОВАННОЙ КЛЕТКИ КАК МИШЕНЬ ПРОТИВООПУХОЛЕВОГО ВОЗДЕЙСТВИЯ
Елена Михайловна Франциянц (2020)
Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors
Yue Zhao (2020)
ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma
X. Deng (2020)
2-Oxoglutarate-dependent dioxygenases in cancer.
J. Losman (2020)
Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications
Qi-ming Wei (2020)
Succinate Activates EMT in Intestinal Epithelial Cells through SUCNR1: A Novel Protagonist in Fistula Development
D. Ortiz-Masia (2020)
Mitochondrial metabolism and cancer metastasis.
Dandan Yu (2020)
The wasting‐associated metabolite succinate disrupts myogenesis and impairs skeletal muscle regeneration
Paige C. Arneson‐Wissink (2020)
Crosstalk between autophagy and metabolic regulation of cancer stem cells
Mouradi El Hout (2020)
Differential microRNA and metabolic expressions in neuroendocrine and cervical carcinomas
Patrick Scicluna (2020)
Oncometabolites and the response to radiotherapy
Kexu Xiang (2020)
Multifaceted Roles of Mitochondrial Components and Metabolites in Metabolic Diseases and Cancer
J. Nakhle (2020)
Metabolic Cancer-Macrophage Crosstalk in the Tumor Microenvironment
Kyra E de Goede (2020)
Mitochondria of transformed cell as a target of antitumor influence
E. M. Frantsiyants (2020)
Succinate Dehydrogenase and Ribonucleic Acid Networks in Cancer and Other Diseases
C. Moreno (2020)
Low levels of AMPK promote epithelial‐mesenchymal transition in lung cancer primarily through HDAC4‐ and HDAC5‐mediated metabolic reprogramming
Shoujie Feng (2020)
Metastasis of pancreatic cancer: An uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal epithelial cells.
Alexander Fabian (2019)
Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis
Demond Williams (2019)
Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor.
Jing-Yiing Wu (2019)
Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells
María José López-Grueso (2019)
TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
W. Hua (2019)
The wasting-associated oncometabolite succinate disrupts myogenesis and impairs skeletal muscle regeneration
Paige C. Arneson (2019)See more